Remdesivir data review: did it help severe COVID patients?
NCT ID NCT04365725
First seen Jan 18, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This study looked back at the medical records of 84 hospitalized adults with severe COVID-19 who received the drug remdesivir. Researchers wanted to see how patients were doing 15 days after starting treatment. The goal was to learn what factors affected their recovery, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.